Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2005
10/12/2005CN1679598A Use of ginseng saponin Rb3 in preparing medicine for treating or preventing cerebrovascular disease
10/12/2005CN1679591A Steroidal sapogenins and their derivatives for treating alzheimer's disease
10/12/2005CN1679583A Pharmaceutical composition comprising condensed indole compound
10/12/2005CN1679566A Milrinone sodium chloride injection and production thereof
10/12/2005CN1679564A Method of treating of demyelinating diseases or conditions
10/12/2005CN1679561A Nimodipine gel for nasal cavity
10/12/2005CN1679560A Stabilized oil-in-water emulsion of matrine alkaloid for venous purpose and production thereof
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679552A Preferential inhibition of release of pro-inflammatory cytokines
10/12/2005CN1679551A Pharmaceutical composition
10/12/2005CN1679545A Andrographolide dispersing tablets
10/12/2005CN1679541A Tea pigment drops and preparation thereof
10/12/2005CN1679537A Single nitrate isosorbide sodium chloride injection
10/12/2005CN1679536A Single nitrate isosorbide delayed-release tablets
10/12/2005CN1679521A Use of substituting nitrobenzene derivative in products preparation
10/12/2005CN1679519A Ginkgo keto-ester soft capsules with long stable effect and preparation thereof
10/12/2005CN1222607C Health wine for reducing blood pressure
10/12/2005CN1222529C Water soluble rapamycin esters
10/12/2005CN1222527C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
10/12/2005CN1222524C Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2, 4-dione maleate and process for their preparation
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222522C Diphenyl azetidinone derivatives, method for prodn. thereof medicaments contg. these compounds, and their use
10/12/2005CN1222520C Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
10/12/2005CN1222510C Novel benzoylguanidine salt
10/12/2005CN1222509C Prostaglandin derives.
10/12/2005CN1222374C Extrusion die
10/12/2005CN1222298C Medicine for treating cardiovascular disease
10/12/2005CN1222288C Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
10/12/2005CN1222286C Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953838 Urocortin-III and uses thereof
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953809 Monocyte chemoattractant protein-1 inhibitor compounds
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953803 Pyrimidine compounds
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953787 5HT2C receptor modulators
10/11/2005US6953780 Endothelin antagonist
10/11/2005US6953667 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease
10/11/2005US6953591 Administering to a mammal non-toxic effective T-cell function-mediated disorder-treating amount of phosphatidyl serine (PS) carrying bodies wherein progression of T-cell function-mediated disorder is inhibited
10/11/2005US6953580 Plant extracts; viricides, blood flow, alopecia
10/11/2005US6953568 Administering biological conjugates that bind preferentially to endothelial protein C receptor(EPCR), to endothelial cells of vascular systems; genetic translocation; drug delivery
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/11/2005CA2341276C Human anti-factor ix/ixa antibodies
10/07/2005CA2504404A1 Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
10/06/2005WO2005093083A1 Method of disease prediction and method of using the same
10/06/2005WO2005093057A1 Truncated dance, dance complex and method of using these
10/06/2005WO2005092367A1 Composition for promoting adiponectin secretion
10/06/2005WO2005092363A1 Preventive/remedy for diabetic complications using oligopeptide
10/06/2005WO2005092354A1 Use of refined, centrifuged pomace oil as an atherosclerosis inhibitor
10/06/2005WO2005092349A1 Insulin resistance improving agent
10/06/2005WO2005092323A1 PARTIAL AGONIST SPECIFIC TO LXRα RECEPTOR
10/06/2005WO2004098499A3 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
10/06/2005US20050223419 Mice which are +/- or -/- for the elastin gene as models for vascular disease
10/06/2005US20050223416 C1 inhibitor produced in the milk of transgenic mammals
10/06/2005US20050222424 Phenyloxyalkanonic acid derivatives as hppar activators
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222418 Novel tyloindicines and related processes, pharmaceutical compositions and methods
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222268 Administering a compound for inhibiting cation exchange as hypotensive agents
10/06/2005US20050222260 (2S)-2-amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
10/06/2005US20050222253 Anti-cancer nitro- and thia-fatty acids
10/06/2005US20050222216 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222191 Solution formulations of sirolimus and its analogs for CAD treatment
10/06/2005US20050222189 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
10/06/2005US20050222181 Compounds in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
10/06/2005US20050222179 Adenosine receptor antagonists and methods of making and using the same
10/06/2005US20050222172 Active ingredient in treating neurodegenerative disease, Alzheimer's disease caused by abnormal enzyme activity
10/06/2005US20050222170 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222155 Inhibitors of akt activity
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore
10/06/2005US20050222138 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
10/06/2005US20050222137 Combination of organic compounds
10/06/2005US20050222120 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidermic conditions
10/06/2005US20050222114 Use of new etonogestrel esters
10/06/2005US20050222105 Nitric ester derivatives of hormones such as progesterone, used for preventing premature labor, increasing cervical dilatation, in hormone replacement therapy, as hypeortensive agents and for treating dysmenorrhea
10/06/2005US20050222092 Use of s1p receptor agonists in heart diseases
10/06/2005US20050222084 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
10/06/2005US20050222077 Administering to a subject before the onset of an ischemic episode at daily dosages of 1-2 g of free CDP-choline (CITICOLINE)
10/06/2005US20050222065 Vascular therapeutics
10/06/2005US20050222061 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/06/2005US20050222041 oligopeptides capable of stimulating neural cell adhesion molecule (NCAM) signalling and/or interfering with cell adhesion, used for treatment of nervous system disorders
10/06/2005US20050222038 Protection against ischemia and reperfusion injury
10/06/2005US20050222025 Method of inhibiting fibrosis with a somatostatin agonist
10/06/2005US20050222020 Apoptotically active peptides
10/06/2005US20050222019 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
10/06/2005US20050222007 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
10/06/2005US20050221483 Propagating pluripotent stem cells from monocytes; tissue engineering; cell therapy; treating cardiovascular, arteriosclerotic, metabolic and liver disorders; cell expressing albumin protein; cirrhosis of the liver
10/06/2005US20050221431 Conjugate having a polypeptide targeting moiety including a sequence of human vascular endothelial growth factor, human annexin V, fragment of anthrax lethal factor, or single chain vascular endothelial growth factor covalently bonded via a disulfide bone to a binding moiety such as an adapter protein
1 ... 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 ... 1595